S‐222611, an oral reversible tyrosine kinase inhibitor of EGFR and HER2. A representative histological image of the colon treated with S‐222611 (25 mg/kg). Issue 8 (August 2014) - Tanaka, Hidekazu; Hirata, Michinari; Shinonome, Satomi; Wada, Toru; Iguchi, Motofumi; Dohi, Keiji; Inoue, Makiko; Ishioka, Yukichi; Hojo, Kanji; Yamada, Tomomi; Sugimoto, Tatsuya; Masuno, Koichi; et al.